本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Silence Therapeutics Plc

12.46
-0.6000-4.59%
盤前10.70-1.7600-14.13%04:00 EDT
成交量:138.34萬
成交額:1,728.30萬
市值:7.50億
市盈率:-9.82
高:13.11
開:13.11
低:12.10
收:13.06
52周最高:17.58
52周最低:4.19
股本:6,020.96萬
流通股本:4,822.70萬
量比:1.55
換手率:2.87%
股息:- -
股息率:- -
每股收益(TTM):-1.2693
每股收益(LYR):-1.8761
淨資產收益率:-90.41%
總資產收益率:-29.65%
市淨率:19.50
市盈率(LYR):-6.64

資料載入中...

2022/02/07

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/10/20

SEC問詢函

CORRESP [Cover] - Correspondence
2021/04/29

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/11

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/11

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/03/09

招股説明書

F-1 - Registration statement for certain foreign private issuers
2021/02/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/09/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/09/02

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/26

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2020/08/20

SEC問詢函

CORRESP [Cover] - Correspondence
2020/08/20

招股説明書

F-1 - Registration statement for certain foreign private issuers
2017/12/08

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2017/12/01

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2017/01/13

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership